Form 4: Compass Therapeutics CEO Thomas Schuetz Reports Stock Transaction
SEC Form 4
CEO Thomas Schuetz of Compass Therapeutics reports disposition of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On February 8, 2025, Thomas J. Schuetz, CEO of Compass Therapeutics, disposed of 41,687 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).
- The transaction was executed at a price of $3.5 per share.
- Following the transaction, Schuetz directly owns 6,470,825 shares of Compass Therapeutics.
- Of these shares, 125,000 represent unvested RSUs granted on November 16, 2021, vesting in four equal annual installments starting November 15, 2022.
- An additional 250,000 shares represent unvested RSUs granted on February 8, 2023, vesting in four equal annual installments starting February 8, 2024.
- Furthermore, 478,125 shares represent unvested RSUs granted on January 9, 2024, vesting in four equal annual installments starting January 9, 2025.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing reflects a routine transaction for tax purposes and doesn't indicate a change in the CEO's overall confidence in the company.
Industry Context
Form 4 filings are standard practice for reporting transactions by company insiders, providing transparency to investors regarding ownership changes.
Key Dates
| Date | Description |
|---|---|
| 11/16/2021 | Grant date of 125,000 unvested RSUs, vesting in four equal annual installments starting November 15, 2022. |
| 02/08/2023 | Grant date of 250,000 unvested RSUs, vesting in four equal annual installments starting February 8, 2024. |
| 01/09/2024 | Grant date of 478,125 unvested RSUs, vesting in four equal annual installments starting January 9, 2025. |
| 02/08/2025 | Date of transaction where 41,687 shares were disposed of to cover tax withholding obligations. |
| 02/11/2025 | Date of signature for the Form 4 filing. |
Keywords
Compass Therapeutics, Thomas Schuetz, CMPX, Form 4, Stock Transaction, CEO, RSUs, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.